Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis Article

Heilberg, IP, Hernandez, E, Alonzo, E et al. (2005). Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis . 27(2), 155-161. 10.1081/JDI-200048241

Open Access International Collaboration

cited authors

  • Heilberg, IP; Hernandez, E; Alonzo, E; Valera, R; Ferreira, LG; Gomes, SA; Bellorin-Font, E; Weisinger, JR

sustainable development goals

authors

publication date

  • January 1, 2005

keywords

  • ALPHA
  • ASSOCIATION
  • ESTRADIOL
  • EXPRESSION
  • FRACTURE RISK
  • HORMONE-REPLACEMENT THERAPY
  • Life Sciences & Biomedicine
  • METABOLISM
  • MODULATORS
  • OSTEOPOROSIS
  • Science & Technology
  • Urology & Nephrology
  • VITAMIN-D-RECEPTOR
  • bone mineral density
  • estrogen receptor polymorphism
  • postmenopausal osteoporosis
  • raloxifene
  • selective estrogen receptor modulator

Location

  • CA, SAN FRANCISCO

Digital Object Identifier (DOI)

publisher

  • TAYLOR & FRANCIS LTD

start page

  • 155

end page

  • 161

volume

  • 27

issue

  • 2